Real-time enrollment status for this cholangiocarcinoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06777316 |
| Recruiting Status | Recruiting |
| Condition | Cholangiocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 110 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Cogent Biosciences, Inc. |
| Last Updated on CT.gov | July 30, 2025 (Jul 30, 2025) |
As of March 2, 2026: Clinical trial NCT06777316 is currently recruiting participants. This clinical trial study for cholangiocarcinoma is actively seeking new participants at 13 locations across the United States. The study is sponsored by Cogent Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06777316 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06777316 was last updated Jul 30, 2025 (July 30, 2025). HelloStudys verifies this status automatically.